Abstract

Metronidazole Benzoate 70 mg/mL in SyrSpend SF Oral Suspension

Author(s): Allen Loyd V Jr

Issue: Jul/Aug 2018 - Volume 22, Number 4

Page(s): 320

Download in electronic PDF format for $75
  • Metronidazole Benzoate 70 mg/mL in SyrSpend SF Oral Suspension Page 1

Abstract

A formulation for preparing Metronidazole Benzoate 70 mg/mL in SyrSpend SF Oral Suspension. Includes ingredients, method of preparation, discussion, and references for the compounding pharmacist.

Related Keywords

  • formulation
  • metronidazole
  • anti-infective agent
  • antibiotic
  • antibacterial agent
  • antiprotozoal agent
  • antimicrobial agent

Related Categories

  • FORMULATIONS
  • INFECTIOUS DISEASE

Printer-Friendly Version

Related Articles from IJPC

Issue/Page
View/Buy		 Title/Author
(Click for Abstract / Details / Purchase)
Jul/Aug 2001
Pg. 310-312
Wetting and/or Solubilizing Agents, Featured Excipient:
Author(s): Allen Loyd V Jr
Jul/Aug 2018
Pg. 320
Metronidazole Benzoate 70 mg/mL in SyrSpend SF Oral Suspension
Author(s): Allen Loyd V Jr
Jan/Feb 2003
Pg. 10-15
View Sample
Compounding for the Effects of Weapons of Mass Destruction
Author(s): Sammarco Domenic A
Mar/Apr 2022
Pg. 94-98
A Compendium of Compounding Agents and Formulations, Part 2: Metronidazole, Misoprostol, and Phenytoin
Author(s): Riepl Mike
Nov/Dec 2008
Pg. 558-564
Stability of Metronidazole Benzoate in SyrSpend SF One-Step Suspension System
Author(s): Vu Nicole T, Aloumanis Vasileios, Ben Michel J, Kupiec Thomas C, Patterson Evelyn K, Radke Joshua, Erickson Martin A III, Schneider Gary
Jan/Feb 2021
Pg. 47
Metronidazole 50-mg/mL in Oral Mix and Oral Mix SF Suspension
Author(s): Allen Loyd V Jr
May/Jun 2004
Pg. 181-185
Compounding in the Pharmacy Curriculum: Beyond the Basics
Author(s): Hinkle Amanda R, Newton Gail D
May/Jun 2020
Pg. 206-212
Basics: Excipients Used in Nonsterile Compounding, Part 6: Compounding with Viscosity-increasing Agents
Author(s): Allen Loyd V Jr
May/Jun 2022
Pg. 238
Metronidazole 7.5 mg/mL Topical Oil-in-Water Microemulsion
Author(s): Allen Loyd V Jr
Jan/Feb 2021
Pg. 24-28
Case Report: The Quest for a Palatable Compounded Metronidazole (Base) Suspension
Author(s): McElhiney Linda F
Jul/Aug 2022
Pg. 270-274
A Compendium of Compounding Agents and Formulations, Part 4: Nifedipine and Pentoxifylline
Author(s): Riepl Mike
Jan/Feb 2020
Pg. 77-82
Stability of Metronidazole Free-base Oral Suspensions Formulated with United States Pharmacopeia-grade Metronidazole Powder and Commercial Metronidazole Tablets
Author(s): Jarouche Marian, Ibrahim Martha, Pearson Jarryd, Low Mitchell, Rowe James
Nov/Dec 2022
Pg. 480-488
A Compendium of Compounding Agents and Formulations, Part 6: Additional Preparations for Refractory Dermal-wound Healing
Author(s): Riepl Mike
Jan/Feb 2020
Pg. 60
Ondansetron Hydrochloride 0.8 mg/mL in SyrSpend SF pH4 Oral Suspension
Author(s): Allen Loyd V Jr
Jan/Feb 2020
Pg. 38-43
Basics: Excipients Used in Nonsterile Compounding, Part 4: Antioxidants and Chelating Agents
Author(s): Allen Loyd V Jr
Jul/Aug 2017
Pg. 301-308
Basics of Sterile Compounding: Excipients Used in Injections
Author(s): Akers Michael J
Nov/Dec 2019
Pg. 504-510
Compatibility of Flavoring Agents in Compounding Extemporaneous Omeprazole Oral Liquid
Author(s): Chuong Monica, Taglieri Catherine A, Huang Szu Yu, Sariol Anthony, Kitigawa Reina, Barman Koushik, Mistry Amee, Harris Donna L, Kerr Stephen G
Jul/Aug 1999
Pg. 309-310
Acidifying Agents, Featured Excipient:
Author(s): Allen Loyd V Jr
Sep/Oct 2022
Pg. 364-368
A Compendium of Compounding Agents and Formulations, Part 5: Timolol and Beta-glucans
Author(s): Riepl Mike
May/Jun 2022
Pg. 189-193
A Compendium of Compounding Agents and Formulations, Part 3: Gentamicin Sulfate and Benzoyl Peroxide
Author(s): Riepl Mike